Guangzhou Wondfo Biotech Co., Ltd.
万孚生物
300482
Shenzhen Stock Exchange
Company Profile
Wondfo was the first Chinese IVD enterprise that has passed FDA on-site test with zero-defect, and was recognized as the National High-Tech Enterprise, NDRC (National Development and Reform Commission) Bioengineering High-Tech Industrial Demonstrative Base as well as Mechanical and Electrical and High-Tech Products Exportation Core Enterprise by Ministry of Commerce. At present, Wondfo is one of the leading enterprises in POC field, and is among the first-rate medical apparatus and instruments manufacturer in China.
Full description
Wondfo is a globally recognized fast growing company devoted to the R&D, manufacture and sales of rapid diagnostic reagents and related equipment in IVD field. With 26 years of development, Wondfo has established a series of technology platforms, such as immunofluorescence quantitative technology platform, immunofluorescence qualitative technology platform, miniature optical detecting instrument technology platform, electrochemistry technology platform, chemiluminescence technology platform, molecular diagnosis technology platform and so on. Using the aforementioned technologies, Wondfo has formed abundant product lines including pregnancy tests, infectious disease tests, drug of abuse tests, chronic disease diagnose. These products are widely applied in the fields of POC, clinical trial, on-site test as well as personal health management.